Visit COVID-19 resources

[Skip to Content]

Comparison among different diagnostic criteria for chronic ocular graft-versus-host disease applied with and without pre-transplant ophthalmological examination – (Comparison among different diagnostic criteria for chronic ocular graft-versus-host disease applied with and without pre-transplant ophthalmological examination, Published online: 2018-09-07; | doi:10.1038/s41433-018-0210-4)

Sep 07
2018

Comparison among different diagnostic criteria for chronic ocular graft-versus-host disease applied with and without pre-transplant ophthalmological examination Comparison among different diagnostic criteria for chronic ocular graft-versus-host disease applied with and without pre-transplant ophthalmological examination, Published online: 07 September 2018; doi:10.1038/s41433-018-0210-4 Comparison among different diagnostic criteria for chronic ocular graft-versus-host disease applied with and without pre-transplant

  • 7 September 2018

Van gogh and the obsession of yellow: style or side effect – (Van gogh and the obsession of yellow: style or side effect, Published online: 2018-09-07; | doi:10.1038/s41433-018-0204-2)

Sep 07
2018

Van gogh and the obsession of yellow: style or side effect Van gogh and the obsession of yellow: style or side effect, Published online: 07 September 2018; doi:10.1038/s41433-018-0204-2 Van gogh and the obsession of yellow: style or side effect

  • 7 September 2018

A novel and effective ophthalmology morbidity and mortality meeting – (A novel and effective ophthalmology morbidity and mortality meeting, Published online: 2018-09-07; | doi:10.1038/s41433-018-0209-x)

Sep 07
2018

A novel and effective ophthalmology morbidity and mortality meeting A novel and effective ophthalmology morbidity and mortality meeting, Published online: 07 September 2018; doi:10.1038/s41433-018-0209-x A novel and effective ophthalmology morbidity and mortality meeting

  • 7 September 2018

Clinical efficacy of eplerenone versus placebo for central serous chorioretinopathy: study protocol for the VICI randomised controlled trial – (Clinical efficacy of eplerenone versus placebo for central serous chorioretinopathy: study protocol for the VICI randomised controlled trial, Published online: 2018-09-07; | doi:10.1038/s41433-018-0212-2)

Sep 07
2018

Clinical efficacy of eplerenone versus placebo for central serous chorioretinopathy: study protocol for the VICI randomised controlled trial Clinical efficacy of eplerenone versus placebo for central serous chorioretinopathy: study protocol for the VICI randomised controlled trial, Published online: 07 September 2018; doi:10.1038/s41433-018-0212-2 Clinical efficacy of eplerenone versus placebo for central serous chorioretinopathy: study protocol for

  • 7 September 2018

Patient outcomes following implantation with a trifocal toric IOL: twelve-month prospective multicentre study – (Patient outcomes following implantation with a trifocal toric IOL: twelve-month prospective multicentre study, Published online: 2018-09-06; | doi:10.1038/s41433-018-0076-5)

Sep 06
2018

Patient outcomes following implantation with a trifocal toric IOL: twelve-month prospective multicentre study Patient outcomes following implantation with a trifocal toric IOL: twelve-month prospective multicentre study, Published online: 06 September 2018; doi:10.1038/s41433-018-0076-5 Patient outcomes following implantation with a trifocal toric IOL: twelve-month prospective multicentre study

  • 6 September 2018